Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome
- PMID: 15507516
- DOI: 10.1210/jc.2004-0229
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome
Abstract
Racial origin and family history of type 2 diabetes impact upon the risk of developing impaired glucose tolerance (IGT) and type 2 diabetes, both of which are common in women with polycystic ovary syndrome (PCOS). We examined the effects of race and family history of type 2 diabetes on the risk of IGT and type 2 diabetes in a large cohort of women with PCOS. Data obtained at baseline were analyzed from 408 premenopausal women with PCOS. Multivariate linear regression models were used to assess the impact of race (white, black, and other) and family history of type 2 diabetes on body mass index, waist circumference, and waist to hip ratio; glycemic measures (glucose and insulin levels obtained during a standard 75-g oral glucose tolerance test, fasting glucose to insulin ratio, and homeostasis model assessment model of insulin resistance derived from fasting levels of glucose and insulin), hemoglobin A(1c), and SHBG, and dehydroepiandrosterone sulfate levels. Sixteen (4%) of the 408 patients had type 2 diabetes, 94 (23%) had IGT, and the remaining 298 (73%) had normal glucose tolerance. A history of type 2 diabetes in either parent (FHxPOS) was present in seven (44%) of the 16 diabetic women with PCOS, 37 (39%) of the 94 women with IGT, and 62 (21%) of those with normal glucose tolerance (P < 0.01, by chi(2) test). The prevalences of IGT and type 2 diabetes were significantly higher in FHxPOS PCOS women compared with FHxNEG PCOS women, IGT evident in 37 (35%) FHxPOS compared with 57 (19%) FHxNEG women, and type 2 diabetes evident in seven (7%) FHxPOS compared with nine (3%) FHxNEG women. Among the 392 nondiabetic subjects, after adjustment for the effects of race, FHxPOS differed significantly from FHxNEG patients in having a higher mean waist to hip ratio, hemoglobin A(1c) level, 2-h glucose level, fasting glucose and insulin levels, glucose to insulin ratio, homeostasis model assessment model of insulin resistance, and areas under the glucose and insulin curves during the oral glucose tolerance test. A family history of type 2 diabetes was present with a significantly greater frequency among women with PCOS who had IGT or type 2 diabetes compared with those with normal glucose tolerance. Conversely, a family history of type 2 diabetes in a first-degree relative was associated with a significantly higher risk for IGT or type 2 diabetes in women with PCOS. Even among nondiabetic women with PCOS, a positive family history of type 2 diabetes was strongly associated with metabolic characteristics associated with an increased risk for type 2 diabetes. Finally, the fasting glucose concentration was poorly associated with 2-h glucose concentrations among PCOS women with IGT, suggesting that the fasting glucose concentration is inadequate to predict the presence of IGT in PCOS.
Similar articles
-
Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.J Clin Endocrinol Metab. 2003 May;88(5):2031-6. doi: 10.1210/jc.2002-021499. J Clin Endocrinol Metab. 2003. PMID: 12727950
-
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.J Clin Endocrinol Metab. 1999 Jan;84(1):165-9. doi: 10.1210/jcem.84.1.5393. J Clin Endocrinol Metab. 1999. PMID: 9920077
-
Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.Gynecol Endocrinol. 2008 Nov;24(11):637-43. doi: 10.1080/09513590802342858. Gynecol Endocrinol. 2008. PMID: 19031221
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
-
Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.Obstet Gynecol Surv. 2004 Feb;59(2):141-54. doi: 10.1097/01.OGX.0000109523.25076.E2. Obstet Gynecol Surv. 2004. PMID: 14752302 Review.
Cited by
-
Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS).Stem Cell Rev Rep. 2024 Jan;20(1):67-87. doi: 10.1007/s12015-023-10627-w. Epub 2023 Sep 28. Stem Cell Rev Rep. 2024. PMID: 37768523 Free PMC article. Review.
-
The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives.Biomedicines. 2023 Mar 23;11(4):998. doi: 10.3390/biomedicines11040998. Biomedicines. 2023. PMID: 37189616 Free PMC article. Review.
-
Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients.Biochem Genet. 2023 Aug;61(4):1418-1432. doi: 10.1007/s10528-022-10327-z. Epub 2023 Jan 12. Biochem Genet. 2023. PMID: 36633772
-
The Efficacy and Safety of Dingkun Pill in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Evid Based Complement Alternat Med. 2022 Aug 24;2022:8698755. doi: 10.1155/2022/8698755. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36062168 Free PMC article. Review.
-
The relationship between polycystic ovary syndrome and insulin resistance from 1983 to 2022: A bibliometric analysis.Front Public Health. 2022 Jul 28;10:960965. doi: 10.3389/fpubh.2022.960965. eCollection 2022. Front Public Health. 2022. PMID: 35968428 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous